Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Matriptase-2
| Catalog | Product Name | EC No. | CAS No. | Source | Price |
|---|---|---|---|---|---|
| NATE-0857 | Matriptase-2 from Human, Recombinant | EC 3.4.21.- | Drosophila Schn... | Inquiry |
Related Reading
Matriptase-2, also known as TMPRSS6 (transmembrane serine protease, serine 6), is a transmembrane serine protease that plays a crucial role in iron metabolism and homeostasis. Matriptase-2 has remarkable properties and essential functions, and has attracted much attention in the field of biological and medical research.
Background
Matriptase-2 was first recognized as a member of the type II transmembrane serine protease family in 2001. Its discovery arose from the need to understand iron metabolism and its regulation. Dysregulation of iron homeostasis has been found to lead to disorders such as hereditary hemochromatosis, which is characterized by excessive accumulation of iron. matriptase-2 is thought to play a key role in the regulation of heme, a hormone that is essential for iron absorption and storage.
Structure
Matriptase-2 consists of multiple structural domains that contribute to its function. These structural domains include a signal peptide, an extracellular structural domain containing protease activity, a transmembrane structural domain, and an intracellular cytoplasmic tail. The extracellular structural domain contains the serine protease catalytic triad that is involved in the enzymatic activity of Matriptase-2. Understanding the structure of Matriptase-2 helps to elucidate its function and interactions in the iron metabolism pathway.
Functions
- Regulation of heparin Heparin is a hormone secreted by the liver that controls iron metabolism. It cleaves and inactivates the hormone hemoglobin, an important activator of heme expression. By decreasing the availability of hemoglobin, Matriptase-2 limits heme production, thereby increasing iron absorption and availability in the body.
- Iron Homeostasis: Matriptase-2's role in iron metabolism is not limited to the regulation of heme. It affects the activity of other proteins involved in iron import, transport, and storage Matriptase-2 regulates the expression of transferrin receptor 2 (TfR2) and hemopexin, both of which are important components of iron sensing and signaling pathways. Through these functions, Matriptase-2 contributes to the maintenance of iron homeostasis in the body.
Applications
- Therapeutic Target
Dysregulation of iron metabolism is associated with various disorders, including iron deficiency anemia and hereditary hemochromatosis. Understanding the molecular mechanisms involving Matriptase-2 presents opportunities for developing therapeutic interventions. Targeting Matriptase-2's activity or expression could help restore iron homeostasis in individuals with iron-related disorders.
- Biomarker for Iron-Related Diseases
Monitoring Matriptase-2 levels has emerged as a potential biomarker for diagnosing and monitoring iron-related diseases. Studies have identified alterations in Matriptase-2 expression and activity in patients with conditions like hereditary hemochromatosis and iron deficiency anemia. Utilizing Matriptase-2 as a diagnostic tool may provide valuable insights into disease progression and treatment response.
Clinical Significance
- Hereditary Hemochromatosis
Matriptase-2 mutations have been implicated in hereditary hemochromatosis, a condition characterized by excessive iron absorption. Understanding the role of Matriptase-2 in iron regulation provides insights into the pathogenesis of this disorder, potentially leading to novel therapeutic strategies.
- Anemia and Iron Deficiency
Matriptase-2's involvement in hepcidin regulation makes it a potential target for treating anemia, particularly iron deficiency anemia. By modulating hepcidin expression and iron availability, therapies targeting Matriptase-2 may enhance iron absorption and red blood cell production in individuals with anemia.
Outlook
Future studies of Matriptase-2 may focus on unraveling its complex regulatory mechanisms and identifying its potential interactions with other proteins involved in iron metabolism. In addition, studying the potential therapeutic applications of modulating Matriptase-2 activity offers hope for patients with iron-related diseases. Understanding the complex role of Matriptase-2 in iron homeostasis will help improve diagnostic and therapeutic strategies for anemia, hereditary hemochromatosis, and other iron-related diseases.